JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4076
ProShares Short VIX Short-Term Futures ETF
SVXY
$264M
| $490K | ﹤0.01% |
18,360
-8,678
| -32% | -$230K |
2018 Q3
3 quarters
|
|
|
AXJV
4077
DELISTED
iShares Edge MSCI Min Vol Asia ex Japan ETF
AXJV
| $489K | ﹤0.01% |
13,554
-310
| -2% | -$11.1K |
2017 Q3
7 quarters
|
|
|
EPZM
4078
PUT
DELISTED
Epizyme, Inc
EPZM
| $488K | ﹤0.01% |
40,000
-35,000
| -47% | -$450K |
2018 Q3
3 quarters
|
|
4079
United Microelectronic
UMC
$58.1B
| $487K | ﹤0.01% |
219,530
-302,335
| -58% | -$618K |
2018 Q4
2 quarters
|
|
4080
Lesaka Technologies
LSAK
$406M
| $485K | ﹤0.01% |
121,373
+55,302
| +84% | +$198K |
2018 Q4
2 quarters
|
|
4081
StoneX
SNEX
$8.08B
| $485K | ﹤0.01% |
64,066
-31,823
| -33% | -$237K |
2015 Q2
16 quarters
|
|
|
OLBK
4082
DELISTED
Old Line Bancshares, Inc.
OLBK
| $485K | ﹤0.01% |
18,579
-5,071
| -21% | -$130K |
2016 Q4
10 quarters
|
|
4083
First Trust US Equity Opportunities ETF
FPX
$1.49B
| $484K | ﹤0.01% |
6,257
-492
| -7% | -$37.4K |
2013 Q3
23 quarters
|
|
4084
MaxLinear
MXL
$9.92B
| $484K | ﹤0.01% |
20,752
+3,142
| +18% | +$76.5K |
2016 Q2
12 quarters
|
|
4085
German American Bancorp
GABC
$1.85B
| $483K | ﹤0.01% |
16,431
+822
| +5% | +$24.2K |
2013 Q2
24 quarters
|
|
4086
WhiteHorse Finance
WHF
$150M
| $483K | ﹤0.01% |
34,919
+10,512
| +43% | +$150K |
2018 Q4
2 quarters
|
|
|
JOYY
4087
CALL
JOYY Inc
JOYY
$3.94B
| $483K | ﹤0.01% |
+7,000
| New | +$534K |
2019 Q2
0 quarters
|
|
|
PZN
4088
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $483K | ﹤0.01% |
56,901
-8,591
| -13% | -$77.8K |
2017 Q3
7 quarters
|
|
|
NTUS
4089
DELISTED
Natus Medical Inc
NTUS
| $483K | ﹤0.01% |
19,104
+4,030
| +27% | +$103K |
2013 Q2
24 quarters
|
|
4090
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$410M
| $482K | ﹤0.01% |
26,158
+100
| +0.4% | +$1.85K |
2013 Q2
24 quarters
|
|
4091
Chemung Financial Corp
CHMG
$397M
| $480K | ﹤0.01% |
10,091
+2,551
| +34% | +$122K |
2016 Q4
10 quarters
|
|
|
FOLD
4092
CALL
DELISTED
Amicus Therapeutics
FOLD
| $480K | ﹤0.01% |
40,000
-250,000
| -86% | -$3.17M |
2019 Q1
1 quarter
|
|
|
FOLD
4093
PUT
DELISTED
Amicus Therapeutics
FOLD
| $480K | ﹤0.01% |
40,000
| – | – |
2019 Q1
1 quarter
|
|
4094
Cohen & Steers Duration Preferred & Income Fund
LDP
$556M
| $480K | ﹤0.01% |
19,295
-1,820
| -9% | -$44.1K |
2017 Q2
8 quarters
|
|
4095
Agilysys
AGYS
$2.8B
| $479K | ﹤0.01% |
22,407
+12,484
| +126% | +$259K |
2015 Q4
14 quarters
|
|
|
HIO
4096
Western Asset High Income Opportunity Fund
HIO
$313M
| $479K | ﹤0.01% |
95,245
| – | – |
2016 Q4
10 quarters
|
|
4097
JELD-WEN Holding
JELD
$157M
| $478K | ﹤0.01% |
22,872
-28,370
| -55% | -$572K |
2017 Q1
9 quarters
|
|
|
PFNX
4098
DELISTED
Pfenex Inc.
PFNX
| $478K | ﹤0.01% |
84,018
+35,418
| +73% | +$226K |
2016 Q2
12 quarters
|
|
4099
Cytokinetics
CYTK
$8.63B
| $477K | ﹤0.01% |
43,036
+31,819
| +284% | +$307K |
2017 Q4
6 quarters
|
|
|
MRSH
4100
PUT
Marsh
MRSH
$82.2B
| $477K | ﹤0.01% |
+4,800
| New | +$459K |
2019 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.